BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6593322)

  • 1. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
    Ishiguro K; Schwartz EL; Sartorelli AC
    J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
    Cheng HW; Armstrong RD; Sadée W
    Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Queuine, a tRNA anticodon wobble base, maintains the proliferative and pluripotent potential of HL-60 cells in the presence of the differentiating agent 6-thioguanine.
    French BT; Patrick DE; Grever MR; Trewyn RW
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):370-4. PubMed ID: 1988936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of leukemia cell differentiation by chemotherapeutic agents.
    Schwartz EL; Ishiguro K; Sartorelli AC
    Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage.
    Gibboney DS; French BT; Patrick DE; Trewyn RW
    Cancer Chemother Pharmacol; 1989; 25(3):189-94. PubMed ID: 2598410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanine analog-induced differentiation of human promyelocytic leukemia cells and changes in queuine modification of tRNA.
    Kretz KA; Katze JR; Trewyn RW
    Mol Cell Biol; 1987 Oct; 7(10):3613-9. PubMed ID: 3479681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine.
    Schwartz EL; Chamberlin H; Brechbühl AB
    Biochem Pharmacol; 1990 Dec; 40(11):2449-55. PubMed ID: 1702632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.
    Huang M; Wang Y; Gu J; Yang J; Noel K; Mitchell BS; Schramm VL; Graves LM
    Leuk Res; 2008 Aug; 32(8):1268-78. PubMed ID: 18279955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
    Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of human promyelocytic leukemia cells in vitro by 6-thioguanine.
    Papac RJ; Brown AE; Schwartz EL; Sartorelli AC
    Cancer Lett; 1980 Jul; 10(1):33-8. PubMed ID: 6939481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5,10-dideazatetrahydrofolic acid (DDATHF).
    Sokoloski JA; Pizzorno G; Beardsley GP; Sartorelli AC
    Oncol Res; 1993; 5(8):293-9. PubMed ID: 8012061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 6-thioguanine on Chlamydia trachomatis growth in wild-type and hypoxanthine-guanine phosphoribosyltransferase-deficient cells.
    Qin B; McClarty G
    J Bacteriol; 1992 May; 174(9):2865-73. PubMed ID: 1569017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of 6-ethylmercaptopurine on c-myc expression in wild-type and HGPRT-deficient HL-60 cells.
    French BT; Patrick DE; Grever MR; Trewyn RW
    Cancer Chemother Pharmacol; 1990; 27(3):171-7. PubMed ID: 2265452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferation and induction of differentiation of human myeloid leukemia cells by novel nucleoside analogs.
    Honma Y; Ikuta T; Kasukabe T; Hozumi M; Itoh T; Ogura H
    Anticancer Res; 1988; 8(4):695-9. PubMed ID: 3178159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.